← All stories
● Covered by 1 source · 1 reportMedium impact

DOJ Shuts Down Criminal Case Against Abbott Laboratories Over Baby Formula

New to BrevFeed? We gather this story from every outlet covering it into one summary — ranked by real-world impact, not just the latest headline — so you never miss what matters. What is BrevFeed? →

Key points

  • DOJ closed a criminal case against Abbott Laboratories over baby formula contamination.
  • Prosecutors directed to close other food and drug industry probes.
  • Higher evidentiary standards implemented for corporate investigations.

Closure of the Abbott Case

The Department of Justice (DOJ) has decided to shut down its long-running criminal investigation into Abbott Laboratories concerning contaminated baby formula that allegedly contributed to infant deaths and illnesses. This closure follows overrules by the deputy attorney general's office, despite previous efforts by the criminal division head, Tysen Duva, to prosecute the company and its executives.

Shift in DOJ Prosecution Strategy

The decision marks a broader retreat in the DOJ's approach to corporate crime, especially concerning food and drug safety. Reports indicate that prosecutors are being directed to close other investigations within these industries, as the department seeks to implement a higher evidentiary standard for pursuing charges.

Background on the Case

The Abbott investigation stemmed from a bacteria outbreak at its Michigan formula plant in 2022. The case suggested potential felony charges, including conspiracy to defraud the U.S., which were ultimately rejected in favor of a civil resolution under the False Claims Act. This change reflects a strategic decision within the DOJ, prioritizing civil agreements over criminal prosecutions.

Industry Reactions and Implications

The closure has raised concerns among consumer protection advocates about the potential decline in corporate accountability, as it may embolden companies in similar circumstances. Furthermore, internal discussions suggested that there was consideration of the impact of criminal charges on Abbott's future investments, including a planned $1 billion facility in Ohio, which is expected to create numerous jobs.

Future of Corporate Investigations

DOJ officials maintain their commitment to enforce federal health and safety laws, stating that they will continue to bring charges where warranted. However, the new thresholds and internal hesitations may lead to a slowdown in the prosecution of corporate misconduct in the drug and food sectors, potentially affecting future enforcement actions.

✨ This summary was generated by AI from the outlets' reporting listed below. It is not independently verified and may contain errors — check the original sources. How BrevFeed works →

The daily brief

One email each morning: the day's tech stories, clustered across outlets and summarized. No account needed.

One email a day. Unsubscribe in one click, any time.

Today's brief

Spend a few minutes, get the whole day. Every topic's top stories in one hands-free rundown — listen, watch, or read the transcript.

~34 min · 27 stories · Oct 02

▶ Play today's brief Listen on Spotify

New every morning, and the back catalogue is archived by date.

Reporting from

The DOJ has closed a criminal investigation into Abbott Laboratories regarding contaminated baby formula. This decision signals a shift towards less aggressive corporate prosecutions in health and safety cases, raising concerns about consumer protection enforcement.